The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A multicenter, open-label, single-arm, phase 1 dose-escalation study to evaluate the safety, tolerability, and anti-tumor activity of FCN-159 in adults with neurofibromatosis type 1.
 
Xiaojie Hu
No Relationships to Disclose
 
Kang Zeng
No Relationships to Disclose
 
Zhongyuan Xu
No Relationships to Disclose
 
Wenbin Li
No Relationships to Disclose
 
Changxing Li
No Relationships to Disclose
 
Zhuang Kang
No Relationships to Disclose
 
Shenglan Li
No Relationships to Disclose
 
Ai-Min Hui
Employment - Fosun Pharma
Leadership - Fosun Pharma
 
Zhuli Wu
Employment - Fosun Pharma
Leadership - Fosun Pharma
 
Xin Huang
Employment - Fosun Pharma
 
Pu Han
Employment - Fosun Pharma
 
Ben Li
Employment - Fosun Pharma
 
Xiaoxi Lin
No Relationships to Disclose